Experience

Davis Polk advised the sales agents in connection with the establishment of an SEC-registered at-the-market offering program by MDU Resources Group, Inc. of up to 10,000,000 shares of…

Davis Polk advised the underwriters in connection with an SEC-registered offering by Weyerhaeuser Company of $750 million aggregate principal amount of its 4.00% senior notes due 2029…

Davis Polk advised the joint book-running managers in connection with a $4.5 billion registered offering by Eli Lilly and Company of $1.15 billion aggregate principal amount of its 3.375%…

Davis Polk is advising Pernix Therapeutics Holdings, Inc. in connection with its restructuring under chapter 11 of the United States Bankruptcy Code, entry into a “stalking horse” asset…

Davis Polk advised the joint book-running managers in connection with a $20 million SEC-registered common stock offering by Sienna Biopharmaceuticals, Inc. The common stock is listed on the…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of $1 billion aggregate principal amount of 6.750% senior notes due 2024…

Davis Polk is advising Attunity Ltd. on its approximately $560 million acquisition by Qlik Technologies Inc. The transaction, which is expected to close in the second quarter of 2019, is…

Davis Polk is advising Millicom International Cellular S.A. on its $1.65 billion acquisition of the entire share capital of Telefónica Móviles Panamá, S.A., Telefónica de Costa Rica TC, S.A…

Davis Polk advised the underwriters in connection with the offering of $2 billion aggregate principal amount of 2.625% U.S. dollar bonds due 2024 issued by Export Development…

We advised the lenders on a superpriority bridge facility